Label: TOAS REJUVENATION- niacinamide cream
-
Contains inactivated NDC Code(s)
NDC Code(s): 72557-004-01, 72557-004-02 - Packager: TOAS Co., Ltd.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated September 24, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- INDICATIONS & USAGE
- DOSAGE & ADMINISTRATION
- WARNINGS
- KEEP OUT OF REACH OF CHILDREN
-
INACTIVE INGREDIENT
Water, Butylene Glycol, Propylene Glycol, Caprylic/Capric Triglyceride, Cetyl Ethylhexanoate, Olea Europaea (Olive) Fruit Oil, 1.2-Hexanediol, Glycerin, Betaine, Cetearyl Alcohol, Macadamia Integrifolia Seed Oil, Vitis Vinifera (Grape) Seed Oil, Beeswax, PEG/PPG-17/6 Copolymer, Polysorbate 60, Butyrospermum Parkii (Shea) Butter, Cyclopentasiloxane, Glyceryl Stearate, Sorbitan Sesquioleate, Glycereth-26, Stearic Acid, Arginine, PEG-100 Stearate, Carbomer, Sodium Hyaluronate, Fragrance, Xanthan Gum, Centella Asiatica Extract, Tocopheryl Acetate, Ethylhexylglycerin, Polygonum Cuspidatum Root Extract, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Chamomilla Recutita (Matricaria) Flower Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Lecithin, Adenosine, Hydrogenated Lecithin, Oligopeptide-1
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
TOAS REJUVENATION
niacinamide creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72557-004 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 0.15 g in 30 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) CETYL ETHYLHEXANOATE (UNII: 134647WMX4) OLIVE OIL (UNII: 6UYK2W1W1E) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) GLYCERIN (UNII: PDC6A3C0OX) BETAINE (UNII: 3SCV180C9W) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) GRAPE SEED OIL (UNII: 930MLC8XGG) PEG/PPG-17/6 COPOLYMER (UNII: P5QZM4T259) POLYSORBATE 60 (UNII: CAL22UVI4M) SHEA BUTTER (UNII: K49155WL9Y) CYCLOMETHICONE 5 (UNII: 0THT5PCI0R) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72557-004-02 1 in 1 CARTON 09/24/2018 1 NDC:72557-004-01 30 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 09/24/2018 Labeler - TOAS Co., Ltd. (694485346) Registrant - TOAS Co., Ltd. (694485346) Establishment Name Address ID/FEI Business Operations TOAS Co., Ltd. 694485346 manufacture(72557-004)